Now showing items 1-2 of 2
Should the patent system for new medicines be abolished?
(Clin Pharmacol Ther, 2007-11)
The price of innovation: new estimates of drug development costs.
(J Health Econ, 2003-03)
The research and development costs of 68 randomly selected new drugs were obtained from a survey of 10 pharmaceutical firms. These data were used to estimate the average pre-tax cost of new drug development. The costs of ...